Results 91 to 100 of about 2,265,539 (159)

Peptide-Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress. [PDF]

Bioengineering (Basel)
Jadhav K, Abhang A, Kole EB, Gadade D, Dusane A, Iyer A, Sharma A, Rout SK, Gholap AD, Naik J, Verma RK, Rojekar S.   +11 more
europepmc   +1 more source

Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics? [PDF]

J Transl Med
Bhat M, Tharmatt A, Bhargava S, Kumeria T, Mishra A, Mittal A, Chitkara D.   +6 more
europepmc   +1 more source

Nanomedicines in diagnosis and treatment of prostate cancers: an updated review. [PDF]

Front Bioeng Biotechnol
Wang J, Zhang X, Xing J, Gao L, Lu H.
europepmc   +1 more source

In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer. [PDF]

Sci Rep
Eluu SC, Obayemi JD, Salifu AA, Yiporo D, Oko AO, Aina T, Oparah JC, Ezeala CC, Etinosa PO, Ugwu CM, Esimone CO, Soboyejo WO.   +11 more
europepmc   +1 more source

Overdiagnosis and Overtreatment in Prostate Cancer. [PDF]

Diseases
Dushimova Z, Iztleuov Y, Chingayeva G, Shepetov A, Mustapayeva N, Shatkovskaya O, Pashimov M, Saliev T.   +7 more
europepmc   +1 more source

Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 study. [PDF]

Int J Clin Oncol
Iwata H, Naito Y, Hattori M, Yoshimura A, Yonemori K, Aizawa M, Mori Y, Yoshimitsu J, Umeyama Y, Mukohara T.   +9 more
europepmc   +1 more source

Immunoprevention of non-viral cancers: challenges and strategies for early intervention. [PDF]

Cancer Cell Int
Biswas K, Kuo LS, Shoemaker RH, Mohammed A.   +3 more
europepmc   +1 more source

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis. [PDF]

J Transl Med
Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA.   +14 more
europepmc   +1 more source

Review of drug-drug interactions in patients with prostate cancer. [PDF]

J Oncol Pharm Pract
Ruplin A, Segal E, McFarlane T.
europepmc   +1 more source

Sex bias in tumor immunity: insights from immune cells. [PDF]

Theranostics
Tao X, Wang Y, Xiang B, Hu D, Xiong W, Liao W, Zhang S, Liu C, Wang X, Zhao Y.   +9 more
europepmc   +1 more source